Loading...
Loading...
Application UK00801548141 · DO-NOT-DISPLAY
| Application Number | UK00801548141 |
| Status | DO-NOT-DISPLAY |
| Owner | Otsuka Pharmaceutical Co., Ltd. |
| Filed | 2020-06-24 |
| Registered | 2021-01-20 |
| Renewal Due | 2030-06-24 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
Rysdeo MyCite has a current status of DO-NOT-DISPLAY.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Pharmaceutical preparations; pharmaceutical preparations for the treatment of central nervous system diseases and disorders; pharmaceutical preparations for the treatment of central nervous system diseases and disorders in the form of ingestible tablets and pills containing sensors (silicon chips); pharmaceutical preparations for the treatment of central nervous system diseases and disorders, containing sensors (silicon chips) which transmit information about drug ingestion by the patient.
Medical apparatus and instruments; medical diagnostic apparatus and instruments; patient monitoring sensors and alarms; sensor apparatus for medical use in monitoring the vital signs of patients; sensor devices and medical apparatus for medical use, namely, sensor patches attached to a patient's body for use in measuring, collecting, storing and transmitting patient data and medical information including drug ingestion information, pulse, heart rate, respiratory rate, body temperature, electric pressure in the body, human motion, human position or sleeping condition.
'Rysdeo MyCite' is a do-not-display trademark on the UK IPO register, owned by Otsuka Pharmaceutical Co., Ltd.. The application (UK00801548141) was filed on 24 June 2020 and registered on 20 January 2021. The registration is set to expire on 24 June 2030.
This mark is recorded under multiple classes: Class 5 (pharmaceuticals & medical preparations); Class 10 (medical & surgical apparatus).
The trademark is represented by BORDERS IP, PPC.
UK trademark UK00801548141 for the mark 'Rysdeo MyCite' in Class 5, 10 is recorded on the UK IPO register as owned by Otsuka Pharmaceutical Co., Ltd.. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
No — the UK IPO records the status of UK trademark UK00801548141 for the mark 'Rysdeo MyCite' as do-not-display.
UK trademark UK00801548141 for the mark 'Rysdeo MyCite' is recorded in Class 5 (pharmaceuticals & medical preparations); Class 10 (medical & surgical apparatus). The filed specification reads: Class 5: Pharmaceutical preparations; pharmaceutical preparations for the treatment of central nervous system diseases and disorders; pharmaceutical preparations for the treatment of central nervous system diseases and disorders in the form of ingestible tablets and pills containing sensors (silicon chips); pharmace…
UK trademark UK00801548141 for the mark 'Rysdeo MyCite' was filed at the UK IPO on 24 June 2020 and registered on 20 January 2021.
UK trademark UK00801548141 for the mark 'Rysdeo MyCite' is currently recorded as valid until 24 June 2030, at which point it will need to be renewed with the UK IPO to remain in force.
BORDERS IP, PPC is listed as the attorney / representative of record for UK trademark UK00801548141 for the mark 'Rysdeo MyCite' on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
Trademarks matching "Rysdeo MyCite" have been found on the following foreign registers. Exact matches appear first; where the name also appears inside longer filings, those are listed below as similar marks. A “Same applicant” badge appears next to a mark when the applicant name aligns with the source filing.
| Mark | Ref | Status | Filed |
|---|---|---|---|
| RYSDEO MYCITESame applicant | 79292766 | 700 | 2020-06-24 |
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
US trademark data is supplied by the United States Patent and Trademark Office. Works of the US federal government are in the public domain under 17 U.S.C. §105.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.